Efficacy, safety, compliance of dermatology products must be improved. Transdermal route must be expanded. Agigma fills a major product gap in these markets.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free